MENU
PRLD
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Prelude Therapeutics (PRLD) Earnings Date & Reports
Prelude Therapeutics Incorp is a precision oncology company developing medicines in areas of high unmet need for cancer patients... Show more
A.I. Advisor
published Earnings
PRLD is expected to report earnings to rise 75.38% to -22 cents per share on August 19
Q2'26
Est.
$-0.23
Q1'26
Beat
by $0.10
Q4'25
Missed
by $0.07
Q3'25
Beat
by $0.11
Q2'25
Beat
by $0.07
The last earnings report on May 12 showed earnings per share of -12 cents, beating the estimate of -23 cents. With 117.03K shares outstanding, the current market capitalization sits at 342.87M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Details
Industry
N/A
Address
175 Innovation Boulevard
Phone
+1 302 467-1280
Employees
79
Web
https://www.preludetx.com